XL TechGroup, Inc. is engaged in the creation and development of new businesses in the areas of BioTech, EcoTech and MedTech sectors. The Company’s portfolio includes TyraTech, Inc. (45.5% owned by XL TechGroup), DxTech LLC (83.7%), GenXL LLC (43.3%), PetroAlgae LLC (94.6%) and QuoNova LLC (88.7%).…
XL TechGroup, Inc. is engaged in the creation and development of new businesses in the areas of BioTech, EcoTech and MedTech sectors. The Company’s portfolio includes TyraTech, Inc. (45.5% owned by XL TechGroup), DxTech LLC (83.7%), GenXL LLC (43.3%), PetroAlgae LLC (94.6%) and QuoNova LLC (88.7%). TyraTech is engaged in the development of a new class of non-toxic, pesticides and anti-parasitic compounds. DxTech is developing a point-of-care diagnostics platform that combines reference lab quality, in real time, with a planned menu of tests. GenXL LLC was established as a joint venture between XL TechGroup and GEN3 Partners, Inc. to generate new companies, stand-alone product lines and technology licensing opportunities from the pipelines of both its founders, as well as from other sources. PetroAlgae is engaged in developing an alternative to petroleum oil. QuoNova is developing anti-virulence agents against infection and damage caused by microbial biofilms.
Team (1)
Sectors XL TechGroup serves:
Life Sciences
Join Axial's Private M&A Platform
XL TechGroup connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
